PUBLIC HEALTH INFORMATION

Remdesivir Therapy Has ‘Little Effect’ on COVID-19 Mortality: WHO Study

Remdesivir therapy, an experimental antiviral therapy that has been used to treat COVID-19, has no substantial effect on a patient’s chances of survival.
Remdesivir Therapy Has ‘Little Effect’ on COVID-19 Mortality: WHO Study
A vial of the drug remdesivir is visually inspected at a Gilead manufacturing site in March 2020. Gilead Sciences via AP
Isabel van Brugen
|Updated:
Remdesivir therapy, an experimental antiviral therapy that has been used to treat COVID-19, has no substantial effect on a patient’s chances of survival, a study by the World Health Organization (WHO) has found.

The antiviral medication, developed by U.S. drugmaker Gilead Sciences, was one of a number of drugs used to treat President Donald Trump following his CCP (Chinese Communist Party) virus diagnosis earlier this month. It is among the first to be used as a treatment for COVID-19, the disease caused by the virus.

Isabel van Brugen
Isabel van Brugen
Reporter
Isabel van Brugen is an award-winning journalist. She holds a master's in newspaper journalism from City, University of London.
twitter
Related Topics